[Skip to Navigation]
Sign In
Views 224
Citations 0
Comment & Response
September 7, 2021

Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis—Reply

Author Affiliations
  • 1Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway
JAMA. 2021;326(9):873. doi:10.1001/jama.2021.10651

In Reply In response to our study on tapering of csDMARDs in patients with RA in remission,1 Dr Baker and colleagues discuss the potential for successful tapering, and even drug-free remission, in RA. They highlight that our study results can be interpreted differently than the main conclusion of the article, which was also discussed in the Editorial by Curtis et al.2

Add or change institution